Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Xeris Biopharma Holdings Inc’s stock clocked out at $3.64, up 1.39% from its previous closing price of $3.59. In other words, the price has increased by $1.39 from its previous closing price. On the day, 1.0 million shares were traded. XERS stock price reached its highest trading level at $3.67 during the session, while it also had its lowest trading level at $3.53.
Ratios:
To gain a deeper understanding of XERS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.29 and its Current Ratio is at 1.79.
On March 28, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
On August 28, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $4.50.Craig Hallum initiated its Buy rating on August 28, 2023, with a $4.50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when Schmid John P. bought 4,515 shares for $2.25 per share. The transaction valued at 10,147 led to the insider holds 25,200 shares of the business.
Schmid John P. bought 4,285 shares of XERS for $10,134 on Aug 09 ’24. The Director now owns 20,685 shares after completing the transaction at $2.37 per share. On May 10 ’24, another insider, Schmid John P., who serves as the Director of the company, bought 5,400 shares for $1.91 each. As a result, the insider paid 10,314 and bolstered with 16,400 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 542654848 and an Enterprise Value of 744219520. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.90. Its current Enterprise Value per Revenue stands at 3.972 whereas that against EBITDA is -22.509.
Stock Price History:
The Beta on a monthly basis for XERS is 1.62, which has changed by 0.36501896 over the last 52 weeks, in comparison to a change of 0.2000997 over the same period for the S&P500. Over the past 52 weeks, XERS has reached a high of $3.87, while it has fallen to a 52-week low of $1.69. The 50-Day Moving Average of the stock is 6.87%, while the 200-Day Moving Average is calculated to be 33.13%.
Shares Statistics:
It appears that XERS traded 1.70M shares on average per day over the past three months and 1575220 shares per day over the past ten days. A total of 149.00M shares are outstanding, with a floating share count of 138.51M. Insiders hold about 7.09% of the company’s shares, while institutions hold 43.86% stake in the company. Shares short for XERS as of 1736899200 were 10361048 with a Short Ratio of 6.08, compared to 1734048000 on 9517445. Therefore, it implies a Short% of Shares Outstanding of 10361048 and a Short% of Float of 7.12.
